Cisplatin

NDC 0703-5747 · Teva Parenteral Medicines, Inc.

Generic nameCisplatin

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)CISPLATIN

Strength50 mg/50mL

Pharmacologic classPlatinum-based Drug [EPC], Platinum-containing Compounds [EXT]

Marketing categoryANDA

Packages

0703-5747-11 — 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5747-11) / 50 mL in 1 VIAL, MULTI-DOSE

J9060 — Injection, cisplatin, powder or solution, 10 mg Medicare Part B payment limit (ASP + 6%): $2.13

FDA lists these products with the same active ingredient.

0143-9504 — Cisplatin, 0143-9505 — Cisplatin, 0703-5748 — Cisplatin, 16729-288 — Cisplatin, 25021-253 — Cisplatin, 44567-509 — CISplatin, 44567-510 — CISplatin, 44567-511 — CISplatin, 44567-530 — cisplatin, 60505-6279 — CISplatin, 63323-103 — CISPLATIN, 68001-283 — Cisplatin, 68001-608 — Cisplatin, 68001-609 — Cisplatin, 68083-162 — Cisplatin, 68083-163 — Cisplatin, 72266-252 — Cisplatin, 72266-253 — Cisplatin

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.